334 related articles for article (PubMed ID: 24966218)
1. Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.
Nair VS; Pritchard CC; Tewari M; Ioannidis JP
Am J Epidemiol; 2014 Jul; 180(2):140-52. PubMed ID: 24966218
[TBL] [Abstract][Full Text] [Related]
2. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
[TBL] [Abstract][Full Text] [Related]
3. Methodological challenges in utilizing miRNAs as circulating biomarkers.
Moldovan L; Batte KE; Trgovcich J; Wisler J; Marsh CB; Piper M
J Cell Mol Med; 2014 Mar; 18(3):371-90. PubMed ID: 24533657
[TBL] [Abstract][Full Text] [Related]
4. Circulating or tissue microRNAs and extracellular vesicles as potential lung cancer biomarkers: a systematic review.
Song Y; Yu X; Zang Z; Zhao G
Int J Biol Markers; 2018 Jan; 33(1):3-9. PubMed ID: 29076520
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs in hematological diseases: principles, challenges, and perspectives.
Grasedieck S; Sorrentino A; Langer C; Buske C; Döhner H; Mertens D; Kuchenbauer F
Blood; 2013 Jun; 121(25):4977-84. PubMed ID: 23550041
[TBL] [Abstract][Full Text] [Related]
6. Current State of Circulating MicroRNAs as Cancer Biomarkers.
He Y; Lin J; Kong D; Huang M; Xu C; Kim TK; Etheridge A; Luo Y; Ding Y; Wang K
Clin Chem; 2015 Sep; 61(9):1138-55. PubMed ID: 26319452
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy.
D'Angelo B; Benedetti E; Cimini A; Giordano A
Anticancer Res; 2016 Nov; 36(11):5571-5575. PubMed ID: 27793880
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of circulating miRNA detection in lung cancer.
Zhao C; Lu F; Chen H; Zhao F; Zhu Z; Zhao X; Chen H
Med Oncol; 2016 May; 33(5):41. PubMed ID: 27034265
[TBL] [Abstract][Full Text] [Related]
9. Study Design and qPCR Data Analysis Guidelines for Reliable Circulating miRNA Biomarker Experiments: A Review.
de Ronde MWJ; Ruijter JM; Moerland PD; Creemers EE; Pinto-Sietsma SJ
Clin Chem; 2018 Sep; 64(9):1308-1318. PubMed ID: 29903876
[TBL] [Abstract][Full Text] [Related]
10. Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals.
Zaporozhchenko IA; Morozkin ES; Ponomaryova AA; Rykova EY; Cherdyntseva NV; Zheravin AA; Pashkovskaya OA; Pokushalov EA; Vlassov VV; Laktionov PP
Sci Rep; 2018 Apr; 8(1):6348. PubMed ID: 29679068
[TBL] [Abstract][Full Text] [Related]
11. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.
Agrawal S; Tapmeier T; Rahmioglu N; Kirtley S; Zondervan K; Becker C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463003
[TBL] [Abstract][Full Text] [Related]
12. Assessment of circulating microRNAs in plasma of lung cancer patients.
Fortunato O; Boeri M; Verri C; Conte D; Mensah M; Suatoni P; Pastorino U; Sozzi G
Molecules; 2014 Mar; 19(3):3038-54. PubMed ID: 24619302
[TBL] [Abstract][Full Text] [Related]
13. Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma.
Song R; Liu Q; Hutvagner G; Nguyen H; Ramamohanarao K; Wong L; Li J
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S16. PubMed ID: 25521201
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma.
Aushev VN; Zborovskaya IB; Laktionov KK; Girard N; Cros MP; Herceg Z; Krutovskikh V
PLoS One; 2013; 8(10):e78649. PubMed ID: 24130905
[TBL] [Abstract][Full Text] [Related]
15. Profiling of circulating microRNAs: from single biomarkers to re-wired networks.
Zampetaki A; Willeit P; Drozdov I; Kiechl S; Mayr M
Cardiovasc Res; 2012 Mar; 93(4):555-62. PubMed ID: 22028337
[TBL] [Abstract][Full Text] [Related]
16. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free microRNAs as clinical cancer biomarkers.
Armand-Labit V; Pradines A
Biomol Concepts; 2017 May; 8(2):61-81. PubMed ID: 28448269
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
